As part of parenteral nutrition to prevent nitrogen loss or treat negative nitrogen balance when alimentary tract cannot be used.

Promote protein synthesis and wound healing, and reduce the rate of endogenous protein catabolism.

Hypersensitivity to one or more amino acids, dextrose, or any component of the formulation.

C

The decision to continue or discontinue breastfeeding during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother.

Cardiovascular: Phlebitis, thrombosis. Dermatologic: Erythema. Endocrine & metabolic: Fluid and electrolyte disturbance. Genitourinary: Azotemia.

IV infusion 500~2500 mL/day. (IV rate: 500 mL/120 min.)

The safety of this product in children has not been established (no clinical experience).

No dosage adjustment necessary.

No dosage adjustment necessary.

Room temperature